Before December 31, 2026, at least three US states will introduce (but not necessarily pass) new laws letting veterans access ibogaine — a plant-based psychedelic — outside the normal federal drug rules. This matters because the federal DEA (US drug enforcement agency) classifies ibogaine as illegal, but states can sometimes work around that. Veteran groups are pushing this hard because early evidence suggests ibogaine helps with PTSD and addiction.
State-level legislative action avoids federal DEA scheduling constraints and is politically viable in high-veteran-population states (Texas, Florida). Momentum from existing pilot advocacy is documented. Falsifiable by a specific numerical threshold (3 states, introduced — not passed) with a hard year-end cutoff.